Physician profile
Anna M Workman
NPI 1225869548
$786.78
in general payments reported to CMS, 2019-2025
19 companies · $678 in 2025
The $678 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $108 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $120.00 | 2025 | Entyvio |
| Genzyme Corporation | $85.79 | 2025 | |
| Ardelyx, INC. | $84.68 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.05 | 2025 | Xifaxan, Relistor |
| Janssen Biotech, INC. | $59.96 | 2025 | Tremfya |
| Abbvie INC. | $54.76 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $45.28 | 2025 | Iqirvo |
| Novo Nordisk INC | $42.85 | 2025 | Wegovy |
| Intercept Pharmaceuticals, INC. | $32.61 | 2024-2025 | |
| Madrigal Pharmaceuticals | $27.52 | 2025 | Rezdiffra |
| Qol Medical, LLC | $23.57 | 2024 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $22.26 | 2025 | Dupixent |
| Gilead Sciences, INC. | $20.28 | 2024 | Livdelzi |
| Braintree Laboratories, INC. | $19.82 | 2025 | Suflave, Sutab |
| Ferring Pharmaceuticals INC. | $19.60 | 2024 | Rebyota |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.65 | 2025 | Omvoh |
| Evoke Pharma, INC. | $17.07 | 2025 | |
| Phathom Pharmaceuticals, INC. | $15.61 | 2025 | Voquezna |
| Exact Sciences Corporation | $14.42 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.